Chronic Cerebral Hypoperfusion Induced Synaptic Proteome Changes in the rat Cerebral Cortex. 2018

Katalin Völgyi, and Péter Gulyássy, and Mihail Ivilinov Todorov, and Gina Puska, and Kata Badics, and Dávid Hlatky, and Katalin Adrienna Kékesi, and Gabriella Nyitrai, and András Czurkó, and László Drahos, and Arpád Dobolyi
MTA-ELTE NAP B Laboratory of Molecular and Systems Neurobiology, Institute of Biology, Hungarian Academy of Sciences and Eötvös Loránd University, Pázmány Péter sétány 1C, Budapest, H-1117, Hungary. katvolgyi@gmail.com.

Chronic cerebral hypoperfusion (CCH) evokes mild cognitive impairment (MCI) and contributes to the progression of vascular dementia and Alzheimer's disease (AD). How CCH induces these neurodegenerative processes that may spread along the synaptic network and whether they are detectable at the synaptic proteome level of the cerebral cortex remains to be established. In the present study, we report the synaptic protein changes in the cerebral cortex after stepwise bilateral common carotid artery occlusion (BCCAO) induced CCH in the rat. The occlusions were confirmed with magnetic resonance angiography 5 weeks after the surgery. Synaptosome fractions were prepared using sucrose gradient centrifugation from cerebral cortex dissected 7 weeks after the occlusion. The synaptic protein differences between the sham operated and CCH groups were analyzed with label-free nanoUHPLC-MS/MS. We identified 46 proteins showing altered abundance due to CCH. In particular, synaptic protein and lipid metabolism, as well as GABA shunt-related proteins showed increased while neurotransmission and synaptic assembly-related proteins showed decreased protein level changes in CCH rats. Protein network analysis of CCH-induced protein alterations suggested the importance of increased synaptic apolipoprotein E (APOE) level as a consequence of CCH. Therefore, the change in APOE level was confirmed with Western blotting. The identified synaptic protein changes would precede the onset of dementia-like symptoms in the CCH model, suggesting their importance in the development of vascular dementia.

UI MeSH Term Description Entries
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D013569 Synapses Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions. Synapse
D013574 Synaptosomes Pinched-off nerve endings and their contents of vesicles and cytoplasm together with the attached subsynaptic area of the membrane of the post-synaptic cell. They are largely artificial structures produced by fractionation after selective centrifugation of nervous tissue homogenates. Synaptosome
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

Katalin Völgyi, and Péter Gulyássy, and Mihail Ivilinov Todorov, and Gina Puska, and Kata Badics, and Dávid Hlatky, and Katalin Adrienna Kékesi, and Gabriella Nyitrai, and András Czurkó, and László Drahos, and Arpád Dobolyi
September 2020, Scientific reports,
Katalin Völgyi, and Péter Gulyássy, and Mihail Ivilinov Todorov, and Gina Puska, and Kata Badics, and Dávid Hlatky, and Katalin Adrienna Kékesi, and Gabriella Nyitrai, and András Czurkó, and László Drahos, and Arpád Dobolyi
October 1998, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology,
Katalin Völgyi, and Péter Gulyássy, and Mihail Ivilinov Todorov, and Gina Puska, and Kata Badics, and Dávid Hlatky, and Katalin Adrienna Kékesi, and Gabriella Nyitrai, and András Czurkó, and László Drahos, and Arpád Dobolyi
January 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
Katalin Völgyi, and Péter Gulyássy, and Mihail Ivilinov Todorov, and Gina Puska, and Kata Badics, and Dávid Hlatky, and Katalin Adrienna Kékesi, and Gabriella Nyitrai, and András Czurkó, and László Drahos, and Arpád Dobolyi
January 2020, Neuroreport,
Katalin Völgyi, and Péter Gulyássy, and Mihail Ivilinov Todorov, and Gina Puska, and Kata Badics, and Dávid Hlatky, and Katalin Adrienna Kékesi, and Gabriella Nyitrai, and András Czurkó, and László Drahos, and Arpád Dobolyi
November 2013, Neurochemical research,
Katalin Völgyi, and Péter Gulyássy, and Mihail Ivilinov Todorov, and Gina Puska, and Kata Badics, and Dávid Hlatky, and Katalin Adrienna Kékesi, and Gabriella Nyitrai, and András Czurkó, and László Drahos, and Arpád Dobolyi
September 2011, Neuroscience letters,
Katalin Völgyi, and Péter Gulyássy, and Mihail Ivilinov Todorov, and Gina Puska, and Kata Badics, and Dávid Hlatky, and Katalin Adrienna Kékesi, and Gabriella Nyitrai, and András Czurkó, and László Drahos, and Arpád Dobolyi
February 2021, Aging,
Katalin Völgyi, and Péter Gulyássy, and Mihail Ivilinov Todorov, and Gina Puska, and Kata Badics, and Dávid Hlatky, and Katalin Adrienna Kékesi, and Gabriella Nyitrai, and András Czurkó, and László Drahos, and Arpád Dobolyi
February 2000, Neurochemical research,
Katalin Völgyi, and Péter Gulyássy, and Mihail Ivilinov Todorov, and Gina Puska, and Kata Badics, and Dávid Hlatky, and Katalin Adrienna Kékesi, and Gabriella Nyitrai, and András Czurkó, and László Drahos, and Arpád Dobolyi
January 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Katalin Völgyi, and Péter Gulyássy, and Mihail Ivilinov Todorov, and Gina Puska, and Kata Badics, and Dávid Hlatky, and Katalin Adrienna Kékesi, and Gabriella Nyitrai, and András Czurkó, and László Drahos, and Arpád Dobolyi
January 1994, Acta neuropathologica,
Copied contents to your clipboard!